3 thoughts on “Sort of Larryesque: Morning Sickness Pill Gets Second Look From Persistent Researchers”
It's notable mostly for this part:
Using a 15-point measure of nausea and vomiting called the PUQE score (who says scientists are humorless!) women taking Diclectin reported a 4.7 point improvement, versus a 3.9 point improvement for women taking placebo.
It's notable mostly for this part:
So that's what the "p" stands for?
"Morning sickness pill?" Too soon for a thalidomide joke?